Genius Brands International Inc (GNUS)

US37229T5092 - Common Stock

3.24  +0.25 (+8.36%)

After market: 3.23 -0.01 (-0.31%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to GNUS. GNUS was compared to 77 industry peers in the Entertainment industry. GNUS may be in some trouble as it scores bad on both profitability and health. GNUS does not seem to be growing, but still is valued expensively.



0

1. Profitability

1.1 Basic Checks

In the past year GNUS has reported negative net income.
In the past year GNUS has reported a negative cash flow from operations.
GNUS had negative earnings in each of the past 5 years.
In the past 5 years GNUS always reported negative operating cash flow.

1.2 Ratios

GNUS has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

GNUS has a worse Gross Margin (19.65%) than 70.67% of its industry peers.
In the last couple of years the Gross Margin of GNUS has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for GNUS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.88%
GM growth 5Y0.53%

2

2. Health

2.1 Basic Checks

GNUS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for GNUS has been increased compared to 1 year ago.
The number of shares outstanding for GNUS has been increased compared to 5 years ago.
The debt/assets ratio for GNUS is higher compared to a year ago.

2.2 Solvency

GNUS has an Altman-Z score of -4.09. This is a bad value and indicates that GNUS is not financially healthy and even has some risk of bankruptcy.
GNUS has a Altman-Z score of -4.09. This is amonst the worse of the industry: GNUS underperforms 80.00% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that GNUS is not too dependend on debt financing.
The Debt to Equity ratio of GNUS (0.02) is better than 70.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF N/A
Altman-Z -4.09
ROIC/WACCN/A
WACC7.88%

2.3 Liquidity

GNUS has a Current Ratio of 1.26. This is a normal value and indicates that GNUS is financially healthy and should not expect problems in meeting its short term obligations.
GNUS has a Current ratio (1.26) which is in line with its industry peers.
GNUS has a Quick Ratio of 1.26. This is a normal value and indicates that GNUS is financially healthy and should not expect problems in meeting its short term obligations.
GNUS has a Quick ratio of 1.26. This is comparable to the rest of the industry: GNUS outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26

3

3. Growth

3.1 Past

The earnings per share for GNUS have decreased strongly by -30.34% in the last year.
GNUS shows a strong growth in Revenue. In the last year, the Revenue has grown by 809.71%.
Measured over the past years, GNUS shows a very strong growth in Revenue. The Revenue has been growing by 63.45% on average per year.
EPS 1Y (TTM)-30.34%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-419.17%
Revenue 1Y (TTM)809.71%
Revenue growth 3Y119.26%
Revenue growth 5Y63.45%
Revenue growth Q2Q884.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y0%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year34.69%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for GNUS. In the last year negative earnings were reported.
Also next year GNUS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for GNUS!.
Industry RankSector Rank
Dividend Yield N/A

Genius Brands International Inc

NASDAQ:GNUS (6/23/2023, 7:00:02 PM)

After market: 3.23 -0.01 (-0.31%)

3.24

+0.25 (+8.36%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap104.06M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 19.65%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-30.34%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y0%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)809.71%
Revenue growth 3Y119.26%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y